Microbiota-Host Transgenomic Metabolism, Bioactive Molecules from the Inside

Area of Science:

• Microbiome research
• Drug discovery
• Medicinal chemistry

Background:

• The gut microbiota is crucial for host metabolic, immunological, and neurological health.
• Gut dysbiosis, an imbalance in the gut microbiome, can lead to disease states.
• Microbiome-derived molecules can contribute to disease pathogenesis.

Purpose of the Study:

• To explore the potential of microbiome-derived metabolites in drug discovery.
• To understand microbiota-host co-regulated pathways for therapeutic intervention.
• To identify novel drug candidates and therapeutic strategies targeting the gut microbiome.

Main Methods:

• Characterization of microbiota-derived metabolites.
• Investigation of microbiota-host co-regulated pathways.
• Exploration of metabolite interactions with human targets.

Main Results:

• Microbiota-derived metabolites show promise as starting hit compounds.
• These metabolites can modulate human targets and elicit pharmacological responses.
• Understanding these pathways enables rational piloting of gut microbiome functions.

Conclusions:

• Drug discovery targeting the gut microbiota represents an innovative medicinal chemistry approach.
• Characterization of microbiota-derived metabolites can lead to novel drug candidates and targets.
• This field offers innovative therapeutic strategies for unmet medical needs.